Caricamento...

Chemotherapy in Androgen-Independent Prostate Cancer (AIPC): What’s next after taxane progression?

Prostate cancer is the most common non-cutaneous cancer in the United States. Although most are diagnosed at earlier stages of disease, a significant number of patients will eventually progress to metastatic androgen-independent prostate cancer (AIPC) and will receive chemotherapy. The benefit of ch...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Aragon-Ching, Jeanny B., Dahut, William L.
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2007
Soggetti:
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC1950481/
https://ncbi.nlm.nih.gov/pubmed/17712400
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !